We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$16.7B
AUM Growth
+$10.2M
(+0.06%)
Cap. Flow
-$510M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
1,686
New
28
Increased
245
Reduced
1,348
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$22.8M |
| 2 |
Cardinal Health
CAH
|
+$16.4M |
| 3 |
Hormel Foods
HRL
|
+$16.3M |
| 4 |
Pentair
PNR
|
+$15.9M |
| 5 |
AbbVie
ABBV
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.1M |
| 2 |
Microsoft
MSFT
|
+$56.8M |
| 3 |
Amazon
AMZN
|
+$50.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.86% |
| 2 | Financials | 13.33% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 10.99% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Denali Therapeutics
DNLI
$3.67B
| $679K | ﹤0.01% |
32,689
-4,522
| -12% | -$101K |
|
902
First Solar
FSLR
$21.8B
| $676K | ﹤0.01% |
10,298
-516
| -5% | -$31K |
|
903
Enanta Pharmaceuticals
ENTA
$372M
| $673K | ﹤0.01% |
7,974
-905
| -10% | -$81.4K |
|
|
ATH
904
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $673K | ﹤0.01% |
15,633
-629
| -4% | -$27.2K |
|
905
Trustmark
TRMK
$2.73B
| $670K | ﹤0.01% |
20,164
-641
| -3% | -$21.7K |
|
906
Globus Medical
GMED
$10.4B
| $669K | ﹤0.01% |
15,812
-1,629
| -9% | -$70.7K |
|
907
Louisiana-Pacific
LPX
$5.2B
| $668K | ﹤0.01% |
25,470
-1,858
| -7% | -$45.5K |
|
|
AKCA
908
DELISTED
Akcea Therapeutics Inc
AKCA
| $668K | ﹤0.01% |
28,507
-3,261
| -10% | -$80.6K |
|
909
Newell Brands
NWL
$2.16B
| $663K | ﹤0.01% |
42,980
-3,487
| -8% | -$52.2K |
|
910
Ironwood Pharmaceuticals
IRWD
$611M
| $660K | ﹤0.01% |
60,328
-20,661
| -26% | -$231K |
|
911
Popular Inc
BPOP
$11B
| $657K | ﹤0.01% |
12,106
-658
| -5% | -$35.9K |
|
912
Equitable Holdings
EQH
$13.1B
| $657K | ﹤0.01% |
31,436
+4,718
| +18% | +$102K |
|
913
Bio-Rad Laboratories Class A
BIO
$8.42B
| $651K | ﹤0.01% |
2,083
-397
| -16% | -$119K |
|
914
Encompass Health
EHC
$11.2B
| $651K | ﹤0.01% |
12,922
-2,397
| -16% | -$116K |
|
915
International Bancshares
IBOC
$4.77B
| $641K | ﹤0.01% |
16,991
-459
| -3% | -$18K |
|
|
TCDA
916
DELISTED
Tricida, Inc. Common Stock
TCDA
| $641K | ﹤0.01% |
16,246
-3
| -0% | -$106 |
|
|
BOLD
917
DELISTED
Audentes Therapeutics, Inc
BOLD
| $639K | ﹤0.01% |
16,877
-1,665
| -9% | -$64K |
|
|
CIT
918
DELISTED
CIT Group Inc.
CIT
| $636K | ﹤0.01% |
12,098
-815
| -6% | -$41.2K |
|
|
NUVA
919
DELISTED
NuVasive, Inc.
NUVA
| $634K | ﹤0.01% |
10,834
-1,104
| -9% | -$65.2K |
|
920
Erie Indemnity
ERIE
$11.7B
| $631K | ﹤0.01% |
2,481
-46
| -2% | -$9.51K |
|
921
Texas Capital Bancshares
TCBI
$4.31B
| $631K | ﹤0.01% |
10,288
-280
| -3% | -$17K |
|
922
LiveRamp
RAMP
$2.29B
| $630K | ﹤0.01% |
12,985
-336
| -3% | -$18.2K |
|
923
AXIS Capital
AXS
$8.59B
| $628K | ﹤0.01% |
10,527
-165
| -2% | -$9.6K |
|
|
AMED
924
DELISTED
Amedisys
AMED
| $625K | ﹤0.01% |
5,151
-164
| -3% | -$19.5K |
|
925
Helen of Troy
HELE
$663M
| $625K | ﹤0.01% |
4,783
-192
| -4% | -$25.1K |
|
Similar funds
ProShare Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ProShare Advisors held 1,686 positions worth $16.7B, up 0.06% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors withdrew a net $510M in Q2 2019, closing 61 positions and reducing 1,348 holdings. Its most notable exit was Bemis, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ProShare Advisors opened a new position in Dow Inc worth $13.3M.
- ProShare Advisors's largest Q2 2019 buy was Dow Inc: 269,509 shares worth $13.3M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q2 2019, an estimated $22.8M increase.
- ProShare Advisors's biggest Q2 2019 reduction was Apple, cutting an estimated $70.1M.
- ProShare Advisors fully exited Bemis in Q2 2019, selling an estimated $12.7M.
- ProShare Advisors's ten largest holdings make up 21% of its $16.7B portfolio in Q2 2019.
- ProShare Advisors opened 28 new positions and closed 61 in Q2 2019.
- ProShare Advisors's portfolio value rose 0.06% quarter-over-quarter to $16.7B.
Based on ProShare Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.